---
title: "CR Double-Crane: The hydrochloride injection of tirofiban and sodium chloride has obtained the drug registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/257504421.md"
description: "CR Double-Crane announced that its wholly-owned subsidiary Anhui Double-Crane Pharmaceutical has obtained the drug registration certificate for Sodium Chloride Injection of Tirofiban Hydrochloride issued by the National Medical Products Administration. This drug is mainly used for patients with non-ST segment elevation acute coronary syndrome to prevent early myocardial infarction and can be used for patients with acute myocardial infarction who are planned for direct PCI to reduce the occurrence of major cardiovascular events"
datetime: "2025-09-16T09:05:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/257504421.md)
  - [en](https://longbridge.com/en/news/257504421.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/257504421.md)
---

# CR Double-Crane: The hydrochloride injection of tirofiban and sodium chloride has obtained the drug registration certificate

According to the announcement from CR Double-Crane (600062.SH), its wholly-owned subsidiary Anhui Double-Crane Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui Double-Crane") has recently received the Drug Registration Certificate for the injection of hydrochloride tirofiban sodium chloride issued by the National Medical Products Administration (hereinafter referred to as "NMPA").

It is reported that the injection of hydrochloride tirofiban sodium chloride is an antiplatelet aggregation drug mainly used for adult patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS) who experience chest pain within 12 hours and have ECG changes and/or elevated myocardial enzymes, to prevent early myocardial infarction. It is also used for patients with ST-segment elevation myocardial infarction (STEMI) who are planned for direct PCI, to reduce the occurrence of major cardiovascular events

### Related Stocks

- [600062.CN](https://longbridge.com/en/quote/600062.CN.md)

## Related News & Research

- [Guriev: Russia is in need of a pipeline to China](https://longbridge.com/en/news/286935918.md)
- [Oil little changed as traders await breakthrough in US.-Iran negotiations](https://longbridge.com/en/news/286925961.md)
- [International Energy Agency Is Wrong To Forecast Coal's Demise](https://longbridge.com/en/news/286899857.md)
- [10:19 ETAARC-360 Completes AICPA Peer Review with Pass Rating](https://longbridge.com/en/news/286929747.md)
- [Russia plans to return staff to Iranian Bushehr nuclear plant in coming weeks, RIA reports](https://longbridge.com/en/news/286905394.md)